OtherLetters to the Editor
Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective trial is on its way.
Jérémie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber and Francesco Ceci
Journal of Nuclear Medicine March 2018, jnumed.118.209965; DOI: https://doi.org/10.2967/jnumed.118.209965
Jérémie Calais
1 UCLA, United States;
Wolfgang Peter Fendler
1 UCLA, United States;
Ken Herrmann
2 Universitätsklinikum Essen, Germany
Matthias Eiber
1 UCLA, United States;
Francesco Ceci
1 UCLA, United States;
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective trial is on its way.
Jérémie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Mar 2018, jnumed.118.209965; DOI: 10.2967/jnumed.118.209965
Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective trial is on its way.
Jérémie Calais, Wolfgang Peter Fendler, Ken Herrmann, Matthias Eiber, Francesco Ceci
Journal of Nuclear Medicine Mar 2018, jnumed.118.209965; DOI: 10.2967/jnumed.118.209965
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.